{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:17:24Z","timestamp":1791559044092,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["2021-I2M-1-046"],"award-info":[{"award-number":["2021-I2M-1-046"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To quantify financial toxicity of female patients with breast cancer in China and investigate its factors and patients\u2019 coping strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Comprehensive Score for Financial Toxicity (COST) is defined by using a structured questionnaire containing 12 items measuring perceived affordability of healthcare services, with the range of scoring of which being from 0 to 44 (higher score indicates lower financial toxicity). From January to March 2021, a total of 664 female patients diagnosed with stage 0\u2013IV breast cancer were recruited from 33 public tertiary cancer hospitals located in 31 provinces of China. Multivariate linear regression models were used.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age of patients was 48\u00a0years (range: 26\u201384\u00a0years), and 62.04% lived in urban areas. The median COST score was 21.00 (interquartile range: 15\u201326). Older age, higher household income, and better self-reported health status were associated with lower financial toxicity, while a bigger household size, being retired or unemployed, stage IV cancer, and a history of targeted therapy were associated with higher financial toxicity (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Nearly half of the patients reported using at least one coping strategy, including considering quitting treatment, delaying treatment, and failing to take medicine or attend medical visits as instructed. The people with increased financial toxicity seem to adopt more coping strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Financial toxicity and coping strategies are common among Chinese women with breast cancer. An understanding of the factors regarding financial toxicity may help oncologists and policy-makers identify at-risk patients and develop targeted interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-022-07264-3","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T13:10:57Z","timestamp":1657631457000},"page":"8231-8240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Financial toxicity in female patients with breast cancer: a national cross-sectional study in China"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-2510","authenticated-orcid":false,"given":"Meicen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-8732","authenticated-orcid":false,"given":"Linlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9521-6311","authenticated-orcid":false,"given":"Man","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-1174","authenticated-orcid":false,"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-1155","authenticated-orcid":false,"given":"Yuanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"issue":"5","key":"7264_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12025","volume":"40","author":"M Cao","year":"2020","unstructured":"Cao M, Li H, Sun D et al (2020) Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond) 40(5):205\u2013210. https:\/\/doi.org\/10.1002\/cac2.12025","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"7264_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"7264_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3760\/cma.j.issn.0253-3766.2016.12.010","volume":"38","author":"JF Shi","year":"2016","unstructured":"Shi JF, Shi CL, Yue XP et al (2016) Economic burden of cancer in China during 1996\u20132014: a systematic review. Zhonghua Zhong Liu Za Zhi 38(12):929\u2013941. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2016.12.010","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"3","key":"7264_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/ajco.12703","volume":"14","author":"XZ Liao","year":"2018","unstructured":"Liao XZ, Shi JF, Liu JS et al (2018) Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross-sectional study. Asia Pac J Clin Oncol 14(3):167\u2013178. https:\/\/doi.org\/10.1111\/ajco.12703","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"7264_CR5","doi-asserted-by":"publisher","first-page":"e2087","DOI":"10.1136\/bmjgh-2019-002087","volume":"5","author":"W Tao","year":"2020","unstructured":"Tao W, Zeng Z, Dang H et al (2020) Towards universal health coverage: achievements and challenges of 10 years of healthcare reform in China. BMJ Glob Health 5(3):e2087. https:\/\/doi.org\/10.1136\/bmjgh-2019-002087","journal-title":"BMJ Glob Health"},{"key":"7264_CR6","unstructured":"The National Healthcare Security Administration (2021) Statistical Bulletin on the Development of National Healthcare Security in 2020. http:\/\/www.nhsa.gov.cn\/art\/2021\/6\/8\/art_7_5232.html. Accessed 4 May 2021."},{"issue":"8","key":"7264_CR7","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1002\/cam4.1590","volume":"7","author":"A Zheng","year":"2018","unstructured":"Zheng A, Duan W, Zhang L et al (2018) How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on \u201cSystem of Health Account 2011\u201d. Cancer Med 7(8):4036\u20134043. https:\/\/doi.org\/10.1002\/cam4.1590","journal-title":"Cancer Med"},{"issue":"7","key":"7264_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3760\/cma.j.issn.0254-6450.2016.07.013","volume":"37","author":"L Wang","year":"2016","unstructured":"Wang L, Zhang Y, Shi JF et al (2016) Disease burden of famale breast cancer in China. Zhonghua Liu Xing Bing Xue Za Zhi 37(7):970\u2013976. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2016.07.013","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"10","key":"7264_CR9","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1007\/s00520-020-05620-9","volume":"28","author":"CJ Longo","year":"2020","unstructured":"Longo CJ, Fitch MI, Banfield L et al (2020) Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Support Care Cancer 28(10):4645\u20134665. https:\/\/doi.org\/10.1007\/s00520-020-05620-9","journal-title":"Support Care Cancer"},{"issue":"12","key":"7264_CR10","doi-asserted-by":"publisher","first-page":"e2025810","DOI":"10.1001\/jamanetworkopen.2020.25810","volume":"3","author":"A Arastu","year":"2020","unstructured":"Arastu A, Patel A, Mohile SG et al (2020) Assessment of financial toxicity among older adults with advanced cancer. JAMA Netw Open 3(12):e2025810. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.25810","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7264_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.annonc.2019.10.006","volume":"31","author":"SZ Hazell","year":"2020","unstructured":"Hazell SZ, Fu W, Hu C et al (2020) Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol 31(1):96\u2013102. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.006","journal-title":"Ann Oncol"},{"key":"7264_CR12","doi-asserted-by":"publisher","first-page":"104521","DOI":"10.1016\/j.oraloncology.2019.104521","volume":"101","author":"WH Beeler","year":"2020","unstructured":"Beeler WH, Bellile EL, Casper KA et al (2020) Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. Oral Oncol 101:104521. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104521","journal-title":"Oral Oncol"},{"issue":"7","key":"7264_CR13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s11136-019-02150-8","volume":"28","author":"R Albelda","year":"2019","unstructured":"Albelda R, Wiemers E, Hahn T et al (2019) Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual Life Res 28(7):1835\u20131847. https:\/\/doi.org\/10.1007\/s11136-019-02150-8","journal-title":"Qual Life Res"},{"issue":"5","key":"7264_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","volume":"199","author":"MM Casilla-Lennon","year":"2018","unstructured":"Casilla-Lennon MM, Choi SK, Deal AM et al (2018) Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life. J Urol 199(5):1166\u20131173. https:\/\/doi.org\/10.1016\/j.juro.2017.10.049","journal-title":"J Urol"},{"issue":"20","key":"7264_CR15","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1002\/cncr.28262","volume":"119","author":"EE Kent","year":"2013","unstructured":"Kent EE, Forsythe LP, Yabroff KR et al (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?. Cancer 119(20):3710\u20133717. https:\/\/doi.org\/10.1002\/cncr.28262","journal-title":"Cancer"},{"issue":"5","key":"7264_CR16","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1245\/s10434-020-09216-9","volume":"28","author":"AN Offodile","year":"2021","unstructured":"Offodile AN, Asaad M, Boukovalas S et al (2021) Financial toxicity following surgical treatment for breast cancer: a cross-sectional pilot study. Ann Surg Oncol 28(5):2451\u20132462. https:\/\/doi.org\/10.1245\/s10434-020-09216-9","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"7264_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00520-019-04915-w","volume":"28","author":"SL Schr\u00f6der","year":"2020","unstructured":"Schr\u00f6der SL, Schumann N, Fink A et al (2020) Coping mechanisms for financial toxicity: a qualitative study of cancer patients\u2019 experiences in Germany. Support Care Cancer 28(3):1131\u20131139. https:\/\/doi.org\/10.1007\/s00520-019-04915-w","journal-title":"Support Care Cancer"},{"issue":"2","key":"7264_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","volume":"68","author":"PM Carrera","year":"2018","unstructured":"Carrera PM, Kantarjian HM, Blinder VS (2018) The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin 68(2):153\u2013165. https:\/\/doi.org\/10.3322\/caac.21443","journal-title":"CA Cancer J Clin"},{"key":"7264_CR19","doi-asserted-by":"publisher","unstructured":"Zafar SY (2016) Financial toxicity of cancer care: it\u2019s time to intervene. J Natl Cancer Inst 108(5). https:\/\/doi.org\/10.1093\/jnci\/djv370","DOI":"10.1093\/jnci\/djv370"},{"issue":"20","key":"7264_CR20","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA de Souza","year":"2014","unstructured":"de Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20):3245\u20133253. https:\/\/doi.org\/10.1002\/cncr.28814","journal-title":"Cancer"},{"issue":"3","key":"7264_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3):476\u2013484. https:\/\/doi.org\/10.1002\/cncr.30369","journal-title":"Cancer"},{"issue":"3","key":"7264_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amjsurg.2019.01.033","volume":"218","author":"N Allcott","year":"2019","unstructured":"Allcott N, Dunham L, Levy D et al (2019) Financial burden amongst cancer patients treated with curative intent surgery alone. Am J Surg 218(3):452\u2013456. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.01.033","journal-title":"Am J Surg"},{"key":"7264_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.oraloncology.2019.06.023","volume":"95","author":"LJ Mady","year":"2019","unstructured":"Mady LJ, Lyu L, Owoc MS et al (2019) Understanding financial toxicity in head and neck cancer survivors. Oral Oncol 95:187\u2013193. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.023","journal-title":"Oral Oncol"},{"issue":"3","key":"7264_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jpainsymman.2019.05.011","volume":"58","author":"LM Perry","year":"2019","unstructured":"Perry LM, Hoerger M, Seibert K et al (2019) Financial strain and physical and emotional quality of life in breast cancer. J Pain Symptom Manage 58(3):454\u2013459. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.05.011","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"7264_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-020-05632-3","volume":"181","author":"J Jing","year":"2020","unstructured":"Jing J, Feng R, Zhang X et al (2020) Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China. Breast Cancer Res Treat 181(2):435\u2013443. https:\/\/doi.org\/10.1007\/s10549-020-05632-3","journal-title":"Breast Cancer Res Treat"},{"key":"7264_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.00003","volume":"5","author":"K Honda","year":"2019","unstructured":"Honda K, Gyawali B, Ando M et al (2019) Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with cancer. J Glob Oncol 5:1\u20138. https:\/\/doi.org\/10.1200\/JGO.19.00003","journal-title":"J Glob Oncol"},{"issue":"10","key":"7264_CR27","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","volume":"2","author":"SF Huntington","year":"2015","unstructured":"Huntington SF, Weiss BM, Vogl DT et al (2015) Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2(10):e408\u2013e416. https:\/\/doi.org\/10.1016\/S2352-3026(15)00151-9","journal-title":"Lancet Haematol"},{"issue":"9","key":"7264_CR28","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1007\/s00520-019-05286-y","volume":"28","author":"CI Ripamonti","year":"2020","unstructured":"Ripamonti CI, Chiesi F, Di Pede P et al (2020) The validation of the Italian version of the COmprehensive Score for financial Toxicity (COST). Support Care Cancer 28(9):4477\u20134485. https:\/\/doi.org\/10.1007\/s00520-019-05286-y","journal-title":"Support Care Cancer"},{"key":"7264_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13508","author":"K Durber","year":"2021","unstructured":"Durber K, Halkett GK, Mcmullen M et al (2021) Measuring financial toxicity in Australian cancer patients - validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients. Asia Pac J Clin Oncol. https:\/\/doi.org\/10.1111\/ajco.13508","journal-title":"Asia Pac J Clin Oncol"},{"issue":"17","key":"7264_CR30","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1002\/cncr.33032","volume":"126","author":"K Hueniken","year":"2020","unstructured":"Hueniken K, Douglas CM, Jethwa AR et al (2020) Measuring financial toxicity incurred after treatment of head and neck cancer: development and validation of the Financial Index of Toxicity questionnaire. Cancer 126(17):4042\u20134050. https:\/\/doi.org\/10.1002\/cncr.33032","journal-title":"Cancer"},{"issue":"8","key":"7264_CR31","first-page":"1118","volume":"38","author":"HH Yu","year":"2017","unstructured":"Yu HH, Bi X, Liu YY (2017) Reliability and validity of the Chinese version on Comprehensive Scores for Financial Toxicity based on the patient-reported outcome measures. Zhonghua Liu Xing Bing Xue Za Zhi 38(8):1118\u20131120","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"7264_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3760\/cma.j.issn.0254-6450.2017.08.024","volume":"19","author":"D Chan","year":"2021","unstructured":"Chan D, Choi KC, Ng M et al (2021) Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2). Health Qual Life Outcomes 19(1):17. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2017.08.024","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"7264_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ygyno.2021.01.040","volume":"161","author":"KM Esselen","year":"2021","unstructured":"Esselen KM, Stack-Dunnbier H, Gompers A, Hacker MR (2021) Crowdsourcing to measure financial toxicity in gynecologic oncology. Gynecol Oncol 161(2):595\u2013600. https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.040","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7264_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2019.04.003","volume":"154","author":"S Bouberhan","year":"2019","unstructured":"Bouberhan S, Shea M, Kennedy A et al (2019) Financial toxicity in gynecologic oncology. Gynecol Oncol 154(1):8\u201312. https:\/\/doi.org\/10.1016\/j.ygyno.2019.04.003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7264_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-019-05449-9","volume":"179","author":"CA Samuel","year":"2020","unstructured":"Samuel CA, Spencer JC, Rosenstein DL et al (2020) Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer. Breast Cancer Res Treat 179(1):207\u2013215. https:\/\/doi.org\/10.1007\/s10549-019-05449-9","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7264_CR36","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1002\/onco.13544","volume":"26","author":"MC Politi","year":"2021","unstructured":"Politi MC, Yen RW, Elwyn G et al (2021) Women who are young, non-white, and with lower socioeconomic status report higher financial toxicity up to 1 year after breast cancer surgery: a mixed-effects regression analysis. Oncologist 26(1):e142\u2013e152. https:\/\/doi.org\/10.1002\/onco.13544","journal-title":"Oncologist"},{"issue":"2","key":"7264_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ygyno.2019.11.022","volume":"156","author":"MI Liang","year":"2020","unstructured":"Liang MI, Pisu M, Summerlin SS et al (2020) Extensive financial hardship among gynecologic cancer patients starting a new line of therapy. Gynecol Oncol 156(2):271\u2013277. https:\/\/doi.org\/10.1016\/j.ygyno.2019.11.022","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7264_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clbc.2020.07.002","volume":"21","author":"C Wan","year":"2021","unstructured":"Wan C, Williams CP, Nipp RD et al (2021) Treatment decision making and financial toxicity in women with metastatic breast cancer. Clin Breast Cancer 21(1):37\u201346. https:\/\/doi.org\/10.1016\/j.clbc.2020.07.002","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"7264_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5582\/bst.2018.01054","volume":"12","author":"G Dou","year":"2018","unstructured":"Dou G, Wang Q, Ying X (2018) Reducing the medical economic burden of health insurance in China: achievements and challenges. Biosci Trends 12(3):215\u2013219. https:\/\/doi.org\/10.5582\/bst.2018.01054","journal-title":"Biosci Trends"},{"issue":"7","key":"7264_CR40","doi-asserted-by":"publisher","first-page":"e006196","DOI":"10.1136\/bmjgh-2021-006196","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wushouer H, Han S et al (2021) The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China. BMJ Glob Health 6(7):e006196. https:\/\/doi.org\/10.1136\/bmjgh-2021-006196","journal-title":"BMJ Glob Health"},{"issue":"4","key":"7264_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist 18(4):381\u2013390. https:\/\/doi.org\/10.1634\/theoncologist.2012-0279","journal-title":"Oncologist"},{"issue":"2","key":"7264_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijrobp.2018.03.014","volume":"101","author":"JD Palmer","year":"2018","unstructured":"Palmer JD, Patel TT, Eldredge-Hindy H et al (2018) Patients undergoing radiation therapy are at risk of financial toxicity: a patient-based prospective survey study. Int J Radiat Oncol Biol Phys 101(2):299\u2013305. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"7264_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.urolonc.2020.09.030","volume":"39","author":"M Ehlers","year":"2021","unstructured":"Ehlers M, Bjurlin M, Gore J et al (2021) A national cross-sectional survey of financial toxicity among bladder cancer patients. Urol Oncol 39(1):71\u201376. https:\/\/doi.org\/10.1016\/j.urolonc.2020.09.030","journal-title":"Urol Oncol"},{"issue":"7","key":"7264_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cncr.29866","volume":"122","author":"EL Warner","year":"2016","unstructured":"Warner EL, Kent EE, Trevino KM et al (2016) Social well-being among adolescents and young adults with cancer: a systematic review. Cancer 122(7):1029\u20131037. https:\/\/doi.org\/10.1002\/cncr.29866","journal-title":"Cancer"},{"issue":"1","key":"7264_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/jayao.2019.0051","volume":"9","author":"HK Kaddas","year":"2020","unstructured":"Kaddas HK, Pannier ST, Mann K et al (2020) Age-related differences in financial toxicity and unmet resource needs among adolescent and young adult cancer patients. J Adolesc Young Adult Oncol 9(1):105\u2013110. https:\/\/doi.org\/10.1089\/jayao.2019.0051","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"5","key":"7264_CR46","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/TA.0000000000002409","volume":"87","author":"PB Murphy","year":"2019","unstructured":"Murphy PB, Severance S, Savage S et al (2019) Financial toxicity is associated with worse physical and emotional long-term outcomes after traumatic injury. J Trauma Acute Care Surg 87(5):1189\u20131196. https:\/\/doi.org\/10.1097\/TA.0000000000002409","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"7264_CR47","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.amjmed.2018.05.020","volume":"131","author":"AM Gilligan","year":"2018","unstructured":"Gilligan AM, Alberts DS, Roe DJ et al (2018) Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer. Am J Med 131(10):1187\u20131199. https:\/\/doi.org\/10.1016\/j.amjmed.2018.05.020","journal-title":"Am J Med"},{"issue":"10","key":"7264_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pon.1156","volume":"16","author":"Y Jiang","year":"2007","unstructured":"Jiang Y, Liu C, Li JY et al (2007) Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psychooncology 16(10):928\u2013936. https:\/\/doi.org\/10.1002\/pon.1156","journal-title":"Psychooncology"},{"issue":"3","key":"7264_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00520-016-3464-z","volume":"25","author":"YH Ni","year":"2017","unstructured":"Ni YH, Alr\u00e6k T (2017) What circumstances lead to non-disclosure of cancer-related information in China? A qualitative study. Support Care Cancer 25(3):811\u2013816. https:\/\/doi.org\/10.1007\/s00520-016-3464-z","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07264-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T09:24:29Z","timestamp":1664184269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07264-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7264"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07264-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Institute of Medical Biology of Chinese Academy of Medical Sciences (IPB-2020\u201323).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}